metricas
covid
Open Respiratory Archives Mepolizumab for Eosinophilic COPD: What Matinee Adds to COPD Management?
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Mepolizumab for Eosinophilic COPD: What Matinee Adds to COPD Management?
Mepolizumab para la epoc eosinofílica: ¿qué añade al manejo del epoc el estudio matinee
Isabel Maria Alcázar-Martíneza,
Corresponding author
isabelalcazar@correo.ugr.es

Corresponding author.
, Pedro Jose Romero-Palaciosa, Bernardino Alcázar-Navarretea,b,c
a Departamento de Medicina, Universidad de Granada, Granada, Spain
b Respiratory Department, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
c CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain
Read
1893
Times
was read the article
293
Total PDF
1600
Total HTML
Share statistics
Article information
ISSN: 26596636
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 325 31 356
2025 11 619 106 725
2025 10 266 48 314
2025 9 346 62 408
2025 8 44 46 90

Follow this link to access the full text of the article